Additional small amounts of diuretics improve blood pressure control at low cost without disadvantages in blood sugar metabolism

Hypertension Research

Volumn 31, Issue 3, 2008, Pages 455-462

  Kudoh, Toshiyuki ^a   Nagawaga, Teruhisa ^a   Nakagawa, Izumi ^a  

^a Eniwa Hospital   (Japan)

Author keywords

Diabetes mellitus; Diuretics; Hypertension; Potassium supplementation

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; INDAPAMIDE; POTASSIUM;

ADULT; AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; CORRELATION ANALYSIS; COST EFFECTIVENESS ANALYSIS; DIABETES MELLITUS; ESSENTIAL HYPERTENSION; FEMALE; FOLLOW UP; FREQUENCY ANALYSIS; GLUCOSE METABOLISM; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTPATIENT CARE; RISK BENEFIT ANALYSIS; SYSTOLIC BLOOD PRESSURE;

ADRENERGIC ANTAGONISTS; AGED; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; BLOOD GLUCOSE; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; DIURETICS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYPERTENSION; LONGITUDINAL STUDIES; MALE; MIDDLE AGED;

EID: 42649086225     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1291/hypres.31.455     Document Type: Article

References (22)

1. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group: Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002; 288: 2981-2997.
2. Julius S, Kjeldsen SE, Weber M, et al: Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial. Lancet 2004; 363: 2022-2031.
3. Davis BR, Piller LB, Cutler JA, et al, Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial Collaborative Research Group: Role of diuretics in the prevention of heart failure: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. Circulation 2006; 113: 2201-2210.
4. Kostis JB, Wilson AC, Freudenberger RS, Cosgrove NM, Pressel SL, Davis BR, SHEP Collaborative Research Group: Long-term effect of diuretic-based therapy on fatal outcomes in subjects with isolated systolic hypertension with and without diabetes. Am J Cardiol 2005; 95: 29-35.
5. Savage PJ, Pressel, SL, Curb JD, et al, SHEP Cooperative Research Group: Influence of long-term, low-dose, diuretic-based, antihypertensive therapy on glucose, lipid, uric acid, and potassium levels in older men and women with isolated systolic hypertension: the Systolic Hypertension in the Elderly Program. Arch Intern Med 1998; 158: 741-751.
6. PROGRESS Collaborative Group: Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet 2001; 358: 1033-1041.
7. Weinehall L, Ohgren B, Persson M, et al: The 'rule of halves' still exists. J Hypertens 2002; 20: 2081-2088.
8. Lang T, de Gaudemaris R, Chatellier G, Hamici L, Diene E, Epidemiology Group of the Societe Francaise d'Hypertension Arterielle and the IHPAF Working Physicians Group: Prevalence and therapeutic control of hypertension in 30,000 subjects in the workplace. Hypertension 2001; 38: 449-454.
9. Alam MG, Barri YM: Systolic blood pressure is the main etiology for poorly controlled hypertension. Am J Hypertens 2003; 16: 140-143.
10. Ono A, Fujita T: Factors relating to inadequate control of blood pressure in hypertensive outpatients. Hypertens Res 2003; 26: 219-224.
11. Saito I, Kawabe H, Tsujioka M, Hirose H, Shibata H: Trends in pharmacologic management of hypertension in Japan one year after the publication of the JSH 2000 guidelines. Hypertens Res 2002; 25: 175-178.
12. Mori H, Ukai H, Yamamoto H, et al: Current status of anti-hypertensive prescription and associated blood pressure control in Japan. Hypertens Res 2006; 29: 143-151.
13. Amar J, Chamontin B, Genes N, Cantet C, Salvador M: Why is hypertension so frequently uncontrolled in secondary prevention. J Hypertens 2003; 21: 1199-1205.
14. Alderman MH, Cohen H, Madhavan S: Diabetes and cardiovascular events in hypertensive patients. Hypertension 1999; 33: 1130-1134.
15. Zillich AJ, Garg J, Basu S, Bakris GL, Carter BL: Thiazide diuretics, potassium, and the development of diabetes: a quantitative review. Hypertension 2006; 48: 198-200.
16. Mason JM, Dickinson HO, Nicolson DJ, Campbell F, Ford GA, Williams B: The diabetogenic potential of thiazide-type diuretic and beta-blocker combinations in patients with hypertension. J Hypertens 2005; 23: 1777-1781.
17. Glynn RJ, L'Italien GJ, Sesso HD, Jackson EA, Buring JE: Development of predictive models for long-term cardiovascular risk associated with systolic and diastolic blood pressure. Hypertension 2002; 39: 105-110.
18. Haider AW, Larson MG, Franklin SS, Levy D: Systolic blood pressure, diastolic blood pressure, and pulse pressure as predictors of risk for congestive heart failure in the Framingham Heart Study. Ann Intern Med 2003; 138: 10-16.
19. Singer G, Izhar M, Black H: Goal-oriented hypertension management: translating clinical trials to practice. Hypertension 2002; 40: 464-469.
20. Inaba M, Noguchi Y, Yamamoto T, et al: Effects of a low dose of indapamide, a diuretic, given daily or every-otherday on blood pressure and metabolic parameters. Hypertens Res 2004; 27: 141-145.
21. Plavinik FL, Rodrigues CI, Zanella MT, Ribeiro AB: Hypokalemia, glucose intolerance, and hyperinsulinemia during diuretic therapy. Hypertension 1992; 19 (2 Suppl): 1126-1129.
22. Curb JD, Pressel SL, Cutler JA, et al: Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group. JAMA 1996; 276: 1886-1892.